Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibacterial cocktail dressing versus standard dressing for burn wound healing
IRCT20180609040016N5Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of acetic acid, povidone-iodine and mafenide in burn injury (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Repair time and Wound infection control. Started Jun 2022; status: completed.
02
Drugs
acetic acidpovidone-iodinemafenide
03
Conditions
burn injury
Beyond the preview
Go deeper on IRCT20180609040016N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180609040016N5.